For help on how to get the results you want, see our search tips.
1794 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Withdrawn applications Remove Withdrawn applications filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Ninlaro (updated)
ixazomib citrate, Multiple Myeloma
Date of authorisation: 21/11/2016,
, 
, 
, Revision: 9, Authorised, Last updated: 03/03/2021
-
List item
Human medicine European public assessment report (EPAR): Maviret (updated)
glecaprevir, pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017,, 
, Revision: 11, Authorised, Last updated: 03/03/2021
-
List item
Human medicine European public assessment report (EPAR): Nexium Control (updated)
esomeprazole, Gastroesophageal Reflux
Date of authorisation: 26/08/2013, Revision: 15, Authorised, Last updated: 03/03/2021 -
List item
Human medicine European public assessment report (EPAR): Tandemact (updated)
pioglitazone, glimepiride, Diabetes Mellitus, Type 2
Date of authorisation: 08/01/2007, Revision: 18, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Glustin (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 11/10/2000, Revision: 26, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
tafamidis, Amyloidosis
Date of authorisation: 16/11/2011,, , 
, Revision: 18, Authorised, Last updated: 02/03/2021
-
List item
Human medicine European public assessment report (EPAR): Neupro (updated)
rotigotine, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 15/02/2006, Revision: 30, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Avamys (updated)
fluticasone furoate, Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial
Date of authorisation: 11/01/2008, Revision: 21, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Moderna (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,, , Authorised, Last updated: 02/03/2021
-
List item
Human medicine European public assessment report (EPAR): DaTSCAN (updated)
ioflupane (123l), Tomography, Emission-Computed, Single-Photon, Lewy Body Disease, Parkinson Disease, Alzheimer Disease
Date of authorisation: 27/07/2000, Revision: 22, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Privigen (updated)
human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic, Bone Marrow Transplantation, Immunologic Deficiency Syndromes, Guillain-Barre Syndrome, Mucocutaneous Lymph Node Syndrome
Date of authorisation: 24/04/2008, Revision: 26, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Zinforo (updated)
Ceftaroline fosamil, Community-Acquired Infections, Skin Diseases, Infectious, Pneumonia
Date of authorisation: 22/08/2012, Revision: 24, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Leganto (updated)
rotigotine, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 16/06/2011, Revision: 19, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Lantus (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 09/06/2000, Revision: 36, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Bortezomib Sun (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,
, Revision: 10, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)
daptomycin, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 22/03/2017,, Revision: 10, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Nucala (updated)
Mepolizumab, Asthma
Date of authorisation: 01/12/2015, Revision: 14, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Velcade (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 26/04/2004, Revision: 44, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Flixabi (updated)
infliximab, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 26/05/2016,, 
, Revision: 16, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Qutenza (updated)
capsaicin, Neuralgia
Date of authorisation: 15/05/2009, Revision: 15, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Karvezide (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 16/10/1998, Revision: 40, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Topotecan Hospira (updated)
topotecan, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 09/06/2010, Revision: 16, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 08/02/2018,, , Revision: 11, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Stelara (updated)
Ustekinumab, Psoriasis, Arthritis, Psoriatic, Crohn Disease
Date of authorisation: 15/01/2009, Revision: 34, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Orfadin (updated)
nitisinone, Tyrosinemias
Date of authorisation: 20/02/2005, Revision: 20, Authorised, Last updated: 01/03/2021